ArticleJournal of thoracic disease2026
A clinician-oriented machine learning model for adult asthma exacerbation prediction: comparative analysis of nine algorithms.
Article in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Asthma exacerbations significantly contribute to morbidity and healthcare burden, yet accurate risk prediction remains challenging. This study aimed to develop and validate a machine learning (ML)-based model to predict the exacerbation risk in adult asthma patients. Methods: This study analyzed data from the National Health and Nutrition Examination Survey (NHANES) collected between 2007 and 2012, comprising a cohort of 1,480 adult participants diagnosed with asthma. A total of 37 candidate features were assessed, and feature selection via least absolute shrinkage and selection operator (LASSO) identified seven key predictors. Nine ML models were developed and evaluated using the area under the curve (AUC) to determine the optimal model. The best-performing model underwent further validation using calibration curves, precision-recall (PR) curves, and decision curve analysis (DCA). Shapley Additive Explanations (SHAP) was applied to interpret the model's predictions. Results: A light gradient boosting machine (LightGBM) model showed the best predictive performance, with an AUC of 0.902 in the training set and comparable discrimination in the validation set. Model performance in the validation cohort showed consistent results across calibration analysis, PR curves, and DCA. Model interpretability was examined using SHAP and a web-based calculator was developed to support individualized risk estimation. Conclusions: This ML-based model demonstrated strong predictive accuracy and could serve as a valuable tool for risk assessment of adult asthma in clinical practice.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.